ABG.F AmerisourceBergen Corporation

Healthcare Health Care Providers & Services Frankfurt Exchange
309.60 EUR
Close of Nov 11, 2026
211.98 325.14
Market cap
EUR 59.1B
P/E
19.8x
P/B
17.81x
ROE
129.6%
Dividend yield
0.78%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is ABG.F undervalued?

Graham number

The Graham number of AmerisourceBergen Corporation cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

AmerisourceBergen Corporation fundamental analysis

No fundamental analysis for AmerisourceBergen Corporation yet.

AmerisourceBergen Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About AmerisourceBergen Corporation

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and o…

Full company profile